EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Co-occurrence of hereditary Tyrosinemia type 1 and refractory immune thrombocytopenia: a case report

Mohammad Fares Zhour, Lamia F Tayem, Saba R Zayed, Hamza S Zeedat, Mohammad Najajreh

Oxford Medical Case Reports · 2026-11-02 · 2026 (11)

DOI: 10.1093/omcr/omag205 ↗
AbstractBibliografische Angaben

Abstract

Abstract Hereditary tyrosinemia type 1 (HT-1) is a rare metabolic disorder caused by fumarylacetoacetate hydrolase deficiency. We report a unique case of HT-1 co-occurring with refractory immune thrombocytopenia (ITP) in a 3.5-year-old female. The patient initially presented at five months with severe thrombocytopenia and coagulopathy. While nitisinone therapy successfully normalized liver function and coagulation parameters, severe thrombocytopenia persisted (<10 × 109/L) despite corticosteroids, IVIG, rituximab, and thrombopoietin receptor agonists. Bone marrow examination showed normal megakaryocytes, and secondary causes were excluded. This distinct dissociation between metabolic control and hematologic refractoriness suggests a complex interplay between metabolic dysregulation and autoimmunity. This is the first reported case of such co-occurrence, highlighting the importance of considering autoimmune complications in metabolic disorders.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →